Nanotheranostics for Treatment and Diagnosis of Infectious Diseases

Dr Keerti Jain earned her MPharm and doctorate degree from the Department of Pharmaceutical Sciences, Dr HS Gour Central University, Sagar, India. She received her post-doctorate degree from Maharaja Sayajirao University of Baroda, Vadodara, India, as SERB-National Post-doctoral Fellow. She has more than 10 years of research experience in nanomedicine-based drug delivery systems. Currently, she is proficiently fulfilling her responsibilities as Assistant Professor and Scientist at the National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, Lucknow, India. Dr Jain has supervised MPharm. and PharmD students in their research, which has been published in quality journals with a high impact factor. She is the author of more than 60 documents in international, peer-reviewed, high-impact journals, including publications in Progress in Polymer Science, having an impact factor of 22.620, Biomaterials, Drug Discovery Today, Nanomedicine, Current Opinion in Pharmacology, Antimicrobial Agents and Chemotherapy, and others with high-impact factors. Her review articles entitled Dendrimer Toxicity: Let’s Meet the Challenge and Dendrimers as Nanocarriers in Drug Delivery, published in the International Journal of Pharmaceutics and Progress in Polymer Science, were listed in the top 25 articles. She has published 1 book and 15 book chapters with international publishers. She has been awarded research fellowships including, SERB – Post-doctorate Fellowship, Senior Research Fellowship (CSIR), Junior Research Fellowship (UGC), Fellowship for Training Young Scientists (MPCST), Travel Grant Award (INSA), and International Travel Fellowship (ICMR and DBT), as well as several other prestigious grants, fellowships, and awards. Dr Javed Ahmad is presently working as an Assistant Professor in Department of Pharmaceutics, College of Pharmacy, Najran University, Najran, Saudi Arabia. He has research experience of about 10 years in the field of nanomedicine-mediated drug delivery. He obtained his PhD in pharmaceutics from Jamia Hamdard, New Delhi, India. He was awarded with senior research fellowships from the Council of Scientific and Industrial Research (CSIR), Government of India. He was also awarded with international travel grants from the Department of Science and Technology (DST), Government of India. He has more than 50 publications to his credit, in various journals of international repute. He has authored 15 book chapters and edited 2 books for CRC Press and Bentham Science Publisher. Currently, he is involved in drug delivery through nanocarriers, exploiting various routes of administration and 3D printing of pharmaceuticals.

• Section I: Fundamental Concept and Drug Delivery Challenges1. Emerging concerns of infectious diseases and drug delivery challenges2. Combating MDR in infectious diseases using nanomaterials3. Theranostic approach to overcome drug delivery challenges in infectious diseasesSection II: Characterization of Nanomaterials for Theranostic Applications4. In-vitro evaluation and spectroscopic characterization of nanomaterials for theranostic applications5. In-vivo evaluation and imaging of nanomaterials for theranostic applicationsSection III: Nanomaterial Applications to Combat Infectious Diseases6. Engineering and functionalization of nanomaterials for theranostic applications in infectious diseases7. Polymeric nanomaterials in infectious diseases8. Stimuli responsive nanomaterials in infectious diseases9. Dendrimers and its theranostic applications in infectious diseases10. Lipid nanomaterials exploited in diagnosis and treatment of infectious diseases11. Liposomes and its theranostic applications in infectious diseases12. Metallic nanomaterials for the diagnosis and treatment of infectious diseases13. Inorganic nanomaterials (carbon nanotube, quantum dots and grapheme): Tuning their properties for theranostic application in infectious diseasesSection IV: Toxicity, Biocompatibility & Regulatory Perspective14. Toxicity and biocompatibility perspective of nanomaterials exploited in diagnosis and treatment of infectious diseases15. Regulatory perspectives of nanomaterials for theranostic application